Substituted-Amidine Functionalized Monocyclic β-Lactams: Synthesis and In Vitro Antibacterial Profile
Background. Owing to the intrinsic stability against common β-lactamases and metallo-lactamases, monobactams gathered special attention in antibiotic drug development. However, so far, aztreonam is the only monobactam approved by FDA for clinical use. We designed new derivatives of aztreonam to enha...
Main Authors: | Lili He, Lijuan Zhai, Jian Sun, Jingwen Ji, Jinbo Ji, Yuanbai Liu, Yangxiu Mu, Yuanyu Gao, Dong Tang, Rui Jiang, Ko Ko Myo, Zaw Min Thu, Haikang Yang, Zafar Iqbal, Zhixiang Yang |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2021-01-01
|
Series: | Journal of Chemistry |
Online Access: | http://dx.doi.org/10.1155/2021/9955206 |
Similar Items
-
Enzymatic synthesis of monocyclic beta-lactams.
by: Sleeman, M, et al.
Published: (2002) -
Mechanistic insights into the inhibition of serine proteases by monocyclic lactams.
by: Wilmouth, R, et al.
Published: (1999) -
Recent Developments to Cope the Antibacterial Resistance via β-Lactamase Inhibition
by: Zafar Iqbal, et al.
Published: (2022-06-01) -
Synthesis and biochemical evaluation of new 3-amido-4-substituted monocyclic ß-lactams as inhibitors of penicillin-binding protein(s)
by: Grabrijan Katarina, et al.
Published: (2024-09-01) -
Monocyclic β-lactams are selective, mechanism-based inhibitors of rhomboid intramembrane proteases.
by: Pierrat, O, et al.
Published: (2011)